CA
NZ
UK
AU
IND
US
Incyte (NASDAQ:INCY) completed its $1.25 billion cash acquisition of Vega Therapeutics on 6 July 2026, adding a Phase 3 antibody for von Willebrand disease, then published multidose data a week later showing a median 81% cut in bleeding rates. With second-quarter results due 28 …
Legend Biotech (NASDAQ:LEGN)'s experimental in vivo CAR-T therapy LB2501 produced responses in every patient treated at the higher of two doses in a 12-patient Phase 1 study, and the shares jumped roughly a third on the news in June. Seven weeks later the stock …
argenx (NASDAQ:ARGX) reported second-quarter Vyvgart net sales of $1.516 billion on 23 July, up 60% year on year and ahead of analyst consensus, and the Nasdaq-listed shares closed 8.6% higher the same day. The company is now durably profitable with $5.2 billion of liquidity, …
Arrowhead (NASDAQ:ARWR) shares closed 19% higher on 22 July 2026 after two Phase 3 studies showed its quarterly injection cut triglycerides by around 80% and reduced acute pancreatitis events in patients with severe hypertriglyceridemia. The data open a market of millions rather than thousands …
Celldex (NASDAQ:CLDX) said on 21 July 2026 that barzolvolimab failed to beat placebo on itch in a 140-patient Phase 2 trial in prurigo nodularis, and that it is abandoning the indication. Shares dropped as much as 10% after hours but closed the next session …
Vertex Pharmaceuticals agreed on 6 July 2026 to buy San Diego endocrine specialist Crinetics (NASDAQ:CRNX) for US$85.00 a share in cash, a 102% premium that sent the stock up roughly 99% the next session. For Crinetics holders the question has shifted from drug development …
Agios (NASDAQ:AGIO) said on 21 July 2026 that it will stop developing tebapivat in sickle cell disease after a Phase 2 study failed to separate convincingly from placebo, and the shares closed down 7.1%. With the same molecule already shelved in myelodysplastic syndromes two …
Behind the roughly 11% pop that placed ZSQR among recent market gainers sits one of the more convoluted corporate histories on the Nasdaq Global Market. The ticker now belongs to Z Squared Inc. (NASDAQ:ZSQR), but the legal entity beneath it has worn two other …
Arhaus, Inc. (NASDAQ:ARHS) rose roughly 10 percent in a recent session, the kind of single-session jump that usually signals a fresh earnings print, revised guidance or a corporate event. For this premium home-furnishings retailer, though, the story is less straightforward than the green arrow …
Callan JMB Inc. (NASDAQ:CJMB) rose roughly 9% on heavy volume, an eye-catching jump for a company whose reported fundamentals have been heading the other way. The most recent verifiable print shows the stock at $2.55, up about 8.5% (or $0.20) at the close, on …
Please wait processing your request...